C Yoshida, A Goda, Y Naito, A Nakaboh… - Journal of …, 2011 - journals.lww.com ... likely be different among the medications [5,6] . Previously, several groups have shown the superiority of angiotensin-convertingenzyme (ACE) inhibitors and/or angiontensin II receptor blockers (ARBs) to calcium channel blockers (CCBs) in the effect of LV mass reduction [6–10 ... Cited by 1 - Related articles - All 5 versions
WJ Elliott - Hypertension and Stroke, 2011 - Springer ... 0.77). After adding data from a study that simply added an ACE inhibitor or placebo to whatever other antihypertensive therapy was required (6,7), the combined relative risk for all 11 studies that reported only Page 3. Chapter ... Cited by 1 - Related articles
[PDF] from adajournal.comY FRONTERA… - 2011 - adajournal.com ... 0 ngiotensin-converting en- zyme inhibitors are being used more frequently to treat hyper- tension. ... A patient under treatment for hypertension with lisinopril, an angiotensin-convertingenzyme Inhibitor, suffered repeated bouts of idiopathic angioedema that resolved when the ... View as HTML
[PDF] from gu.seP Hallersund - 2011 - gupea.ub.gu.se ... I. Hallersund P, Helander HF, Casselbrant A, Edebo A, Fändriks L, Elfvin A. ngiotensin II receptor ... angiotensin II (AngII) by angiotensin‐convertingenzyme (ACE) expressed by endothelial ... For example, experiments in rats given ACE‐inhibitors (decreasing AngII generation) have ... Related articles
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
